Recruiting
Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer
NCT07049133
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
- Locations
-
- European Institute of Oncolgy Milan, Italy